- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-MyoAAV 3A vector system (AAV-MyoAAV 3A expression system, AAV-MyoAAV 3A packaging plasmid system) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV-MyoAAV 3A Vector system is including: 1) AAV-MyoAAV 3A Rep-Cap plasmid (AAV-MyoAAV 3A-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV-MyoAAV 3A particle in 293T cell line in high titer using GeneMedi's AAV-MyoAAV 3A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
MyoAAV3A might offer improved transduction rates or a different tissue specificity profile within the muscle tissue spectrum, possibly targeting specific muscle types more effectively than other variants. Adjustments to capsid proteins to enhance binding to muscle cell receptors or to evade immune recognition could characterize this variant.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Manual
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-PK32 | AAV-MyoAAV 3A Vector System (Amp resistance) 1. MyoAAV 3A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | ||
| P-PK32 | AAV-MyoAAV 3A Vector System (Amp resistance) 1. MyoAAV 3A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-PK32 | AAV-MyoAAV 3A Vector System (Amp resistance) 1. MyoAAV 3A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK32 | AAV-MyoAAV 3A Vector System (Amp resistance) 1. MyoAAV 3A Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK32-Kan | AAV-MyoAAV 3A Vector System (Kan resistance) 1. MyoAAV 3A Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC32 | AAV-MyoAAV 3A Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 2062 | ||
| P-RC32 | AAV-MyoAAV 3A Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-RC32 | AAV-MyoAAV 3A Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC32 | AAV-MyoAAV 3A Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC32-Kan | AAV-MyoAAV 3A Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Pancreatic acinar cells-derived sphingosine-1-phosphate contributes to fibrosis of chronic pancreatitis via inducing autophagy and activation of pancreatic stellate cells | Gastroenterology | 2023/8/25 |
| Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage | Nature Neuroscience | 2023/11/23 |
| ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer's disease | Molecular Neurodegeneration | 2023/7/12 |
| Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism-Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu | Advanced Science | 2023/2/19 |
| Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation | Nature Communications | 2023/10/21 |
| Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target | Science Advances | 2023/5/31 |
| Pharmacological manipulation of macrophage autophagy effectively rejuvenates the regenerative potential of biodegrading vascular graft in aging body | Bioactive Materials | 2021/10/20 |
| Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation | Molecular Psychiatry | 2022/10/24 |
| Targeted m6A Demethylation of ITGA6 mRNA by a Multisite dCasRx–m6A Editor Inhibits Bladder Cancer Development | Journal of Advanced Research | 2023/3/30 |
| Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics | Experimental & Molecular Medicine | 2022/11/25 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
